Abstract
Objective Evaluate and map data science methods employed to solve health conditions of women, examine the problems tackled and the effectiveness.
Research Method Text analytics, science mapping, and descriptive evaluation of data science methods utilized in women-related health research.
Findings (i). The trends in scholarships using data science methods indicate gaps between women and men relating to health burden and access to health. (ii). The coronavirus (SARS-CoV-2) outbreak and the ongoing COVID-19 pandemic tend to widen the identified health gaps, increasing the disease burden for women, while reducing access to health. There are noticeable additional health burdens on pregnant women and those with several health conditions (breast cancer, gynecologic oncology, cardiovascular disease, and more). (iii). Over 95% of studies using data science methods (artificial intelligence, machine learning, novel algorithms, predictive, big data, visual analytics, clinical decision support systems, or a combination of the methods) indicate significant effectiveness. (iv). Mapping of the scientific literature to authors, sources, and countries show an upward trend; 997 (16%), 113 (1.33%), and 57 (2.63%) per article, respectively. About 95% of research utilizing data science methods in women’s health studies occurred within the last four (4) years.
Conclusions The application of data science methods in tackling different health problems of women is effective and growing, and capable of easing the burden of health in women. The ongoing COVID-19 pandemic tends to compound the health burden for women more than men. Policymakers must do more to improve access to health for women.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Not Applicable.
